<DOC>
	<DOCNO>NCT02415101</DOCNO>
	<brief_summary>This study compare outcomes regard time resective surgery neoadjuvant chemoradiotherapy ( CRT ) cancer esophagus gastric cardia . Patients randomise surgery either conventional 4-6 10-12 week termination CRT . The study hypothesis longer delay improve histological response decrease risk postoperative morbidity mortality .</brief_summary>
	<brief_title>Timing Resective Surgery After Neoadjuvant Chemoradiotherapy Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Histologically verify adenocarcinoma SCC esophagus GEJ Siewert type I II . Tumors resectable without distant metastasis , assess complete CRT . Patients performance status 01 accord Eastern Cooperative Oncology Group ( ECOG ) scale pre CRT evaluation judge fit surgery pre post CRT evaluation . Pre CRT tumor stage : T1N13M0 , T2N03M0 , T3N03 , M0 , T4aN03 , M0 Written inform consent Completed least 80 % plan chemotherapy least 90 % prescribed radiotherapy dose within neoadjuvant CRT schedule accord protocol within period &lt; 36 day . Concomitant malignant diagnosis ( exclude nonmelanoma skin cancer ) &lt; 5 year since current cancer diagnosis . Ongoing antitumoral treatment irrespective time since diagnosis earlier malignancy . Patients unable comply protocol reason language cognitive function . Tumor stage T1N0 , T4bNX TXNXM1 . Carcinoma upper third esophagus ( i.e . cervical uppermost thoracic ) simplicity define upper border tumor 22 cm incisor endoscopy . Clear radiological sign tumor progression CRT CTscan completion CRT . PET use decision FDGactivity often increase due radiotherapy induced inflammation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Adenocarcinoma</keyword>
	<keyword>Squamous cell carcinoma</keyword>
	<keyword>Gastroesophageal Junction</keyword>
</DOC>